Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administ…

Biotechnology

US, Radnor [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Mergers & Acquisitions Beta

M&As

MLYS M&As
Biotechnology M&A

M&A Deals · Breakdown

Mineralys Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Mineralys Therapeutics, Inc. has no acquisition track records yet.